QUANTRX BIOMEDICAL CORP — Form D

QUANTRX BIOMEDICAL CORP of DOYLESTOWN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2009-08-14. The offering totals $406.0M, of which $406.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2009-08-14
• Form: D
• Accession: 0001144204-09-043755
• Industry: Biotechnology
• Exemptions: 06
• Total offering: $406.0M
• Amount sold: $406.0M
• Investors: 13
• Date of first sale: 2009-07-30
• Security types: equity
• Revenue range: $1 - $1,000,000
• SEC file number: 021-82060-8S

Issuer

• Name: QUANTRX BIOMEDICAL CORP
• CIK: 0000820608
• Entity type: Corporation
• Jurisdiction: NEVADA
• Address: 100 SOUTH MAIN STREET, DOYLESTOWN, PA, 18901
• Phone: 267-880-1595

Officers, directors & promoters (3)

More

• CIK 820608 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search